Objectives This systematic review aims to summarize the mycological and clinical features of
COVID-19-associated fungal infections (CAFIs) in Iran. Methods PubMed, Web of Science …

The COVID-19 patients, both infected and recovered are rapidly contracting mucormycetes
infections due to the 'Mucorales' order, under Zygomycetes class of fungi. The mucorales …

Although mucormycosis may have reached an epidemic situation during the COVID-19
pandemic, the term was much more familiar even before the COVID-19 period. The year …

Introduction Despite the high prevalence of hypocalcemia in patients with COVID-19, very
limited studies have been designed to evaluate etiologies of this disorder. This study was …

The post-coronavirus disease (COVID-19) mucormycosis is a deadly addition to the
pandemic spectrum. Although it'sa rare, aggressive, and opportunistic disease, the …

Objectives Studies reviewing orofacial mycoses in coronavirus disease-2019 (COVID-19)
caused by severe acute respiratory syndrome 2 (SARS-CoV-2) infection are sparse. Here …

Purpose To assess whether transcutaneous retrobulbar amphotericin B injections (TRAMB)
reduce exenteration rate without increasing mortality in rhino-orbital-cerebral mucormycosis …

Mucormycosis has a significant impact on patients' standard of living and, therefore, a high
clinical suspicion, prediagnosis, and rapid treatment are critical in easing patients' suffering …

Mucormycosis is a highly aggressive angio-invasive disease of humans caused by fungi in
the zygomycete order, Mucorales. Though a number of different species can cause …

Mucormycosis is a rare fungal infection mainly affecting immunocompromised patients.
Recently, an alarming rise in cases of mucormycosis was observed in patients undergoing …